Diagnostic reliability of Architect anti-HCV assay: Experience of a tertiary care hospital in India.
Gnanadurai John FletcherAnantharam RaghavendranJayashree SivakumarPrasanna SamuelPriya AbrahamPublished in: Journal of clinical laboratory analysis (2017)
Architect can be used as a screening assay because of its high sensitivity, high throughput, and short turnaround time. However, S/Co ratios of ≥1 to <8 in Architect necessitates HCV PCR to identify current infection and or EIA to distinguish true positivity from false biological positivity.